IndexIQ Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

IndexIQ Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$12.9M	Buy	+692,994	New	+$12.5M	0.46%	45

Other funds holding OCDX

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

IndexIQ Advisors's OCDX Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022: 692,994 shares worth $12.9M. The stake represents 0.46% of the portfolio and ranks #45 among its holdings.

170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

IndexIQ Advisors held 692,994 shares of Ortho Clinical Diagnostics Holdings plc Ordinary Shares worth $12.9M as of Q1 2022.
Ortho Clinical Diagnostics Holdings plc Ordinary Shares was a new IndexIQ Advisors position in Q1 2022.
Ortho Clinical Diagnostics Holdings plc Ordinary Shares made up 0.46% of IndexIQ Advisors's portfolio in Q1 2022, its #45 holding.
170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.